The mechanism of topoisomerase I poisoning by a camptothecin analog
Top Cited Papers
- 8 November 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (24) , 15387-15392
- https://doi.org/10.1073/pnas.242259599
Abstract
We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clinically approved anticancer agent Topotecan. Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (−1) and downstream (+1) base pairs. Intercalation displaces the downstream DNA, thus preventing religation of the cleaved strand. By specifically binding to the enzyme–substrate complex, Topotecan acts as an uncompetitive inhibitor. The structure can explain several of the known structure–activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme. The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.Keywords
This publication has 53 references indexed in Scilit:
- A standard reference frame for the description of nucleic acid base-pair geometryJournal of Molecular Biology, 2001
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Tumor Cell Death Induced by Topoisomerase-Targeting DrugsAnnual Review of Pharmacology and Toxicology, 2001
- A-form Conformational Motifs in Ligand-bound DNA StructuresJournal of Molecular Biology, 2000
- Structural Flexibility in Human Topoisomerase I Revealed in Multiple Non-isomorphous Crystal StructuresJournal of Molecular Biology, 1999
- XtalView/Xfit—A Versatile Program for Manipulating Atomic Coordinates and Electron DensityJournal of Structural Biology, 1999
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- AMoRe: an automated package for molecular replacementActa Crystallographica Section A Foundations of Crystallography, 1994
- Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell lineBiochemical and Biophysical Research Communications, 1992
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966